{
    "organizations": [],
    "uuid": "86810e7b5dd7fc0d5fc6751c56fbfe3c764fe235",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tocagen-and-apollobio-enter-licens/brief-tocagen-and-apollobio-enter-license-agreement-to-develop-toca-511-toca-fc-in-greater-china-idUSFWN1RW0L5",
    "ord_in_thread": 0,
    "title": "BRIEF-Tocagen And ApolloBio Enter License Agreement To Develop Toca 511 & Toca FC In Greater China",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Tocagen Inc:\n* TOCAGEN AND APOLLOBIO ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE TOCA 511 & TOCA FC IN THE GREATER CHINA REGION\n* TOCAGEN INC - TOCAGEN ELIGIBLE TO RECEIVE UP TO $127 MILLION IN UPFRONT PAYMENT, DEVELOPMENT AND COMMERCIAL MILESTONES\n* TOCAGEN - ELIGIBLE TO RECEIVE ADDITIONAL DOUBLE-DIGIT TIERED SALES ROYALTIES UPFRONT AND NEAR-TERM DEVELOPMENT MILESTONES PAYMENTS TOTAL UP TO $20 MILLION\n* TOCAGEN INC - WILL BE ELIGIBLE FOR ADDITIONAL FUTURE PAYMENTS TOTALING UP TO $111 MILLION UPON MEETING CERTAIN DEVELOPMENT AND COMMERCIAL MILESTONES\n* TOCAGEN INC - WILL BE RESPONSIBLE FOR ALL DEVELOPMENT AND COMMERCIALIZATION COSTS IN LICENSED TERRITORY\n* TOCAGEN INC - LICENSE GRANT TO APOLLOBIO IS EXPECTED TO BECOME EFFECTIVE IN Q2 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T20:07:00.000+03:00",
    "crawled": "2018-04-20T11:31:59.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "tocagen",
        "inc",
        "tocagen",
        "apollobio",
        "enter",
        "license",
        "agreement",
        "develop",
        "commercialize",
        "toca",
        "toca",
        "fc",
        "greater",
        "china",
        "region",
        "tocagen",
        "inc",
        "tocagen",
        "eligible",
        "receive",
        "million",
        "upfront",
        "payment",
        "development",
        "commercial",
        "milestone",
        "tocagen",
        "eligible",
        "receive",
        "additional",
        "tiered",
        "sale",
        "royalty",
        "upfront",
        "development",
        "milestone",
        "payment",
        "total",
        "million",
        "tocagen",
        "inc",
        "eligible",
        "additional",
        "future",
        "payment",
        "totaling",
        "million",
        "upon",
        "meeting",
        "certain",
        "development",
        "commercial",
        "milestone",
        "tocagen",
        "inc",
        "responsible",
        "development",
        "commercialization",
        "cost",
        "licensed",
        "territory",
        "tocagen",
        "inc",
        "license",
        "grant",
        "apollobio",
        "expected",
        "become",
        "effective",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}